Maven Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,900
Closed -$645K 512
2025
Q4
$645K Buy
+25,900
New +$653K 0.01% 417
2025
Q3
Sell
-71,200
Closed -$1.73M 744
2025
Q2
$1.73M Buy
+71,200
New +$1.66M 0.04% 336
2025
Q1
Sell
-198,400
Closed -$5.26M 945
2024
Q4
$5.26M Buy
+198,400
New +$5.38M 0.13% 132
2023
Q4
Sell
-28,200
Closed -$935K 1144
2023
Q3
$935K Buy
+28,200
New +$997K 0.01% 641
2023
Q2
Sell
-27,800
Closed -$1.13M 1007
2023
Q1
$1.13M Sell
27,800
-8,900
-24% -$384K 0.02% 427
2022
Q4
$1.87M Buy
36,700
+14,400
+65% +$690K 0.04% 270
2022
Q3
$976K Buy
+22,300
New +$1.08M 0.02% 547
2022
Q2
Sell
-6,400
Closed -$331K 1063
2022
Q1
$331K Buy
6,400
+2,000
+45% +$104K 0.01% 673
2021
Q4
$260K Sell
4,400
-18,100
-80% -$897K 0.01% 725
2021
Q3
$968K Sell
22,500
-28,300
-56% -$1.25M 0.03% 458
2021
Q2
$1.99M Buy
+50,800
New +$1.98M 0.08% 237
2020
Q3
Sell
-20,869
Closed -$641K 718
2020
Q2
$641K Sell
20,869
-9,592
-31% -$326K 0.04% 269
2020
Q1
$943K Sell
30,461
-632
-2% -$21.5K 0.11% 122
2019
Q4
$1.16M Buy
+31,093
New +$1.11M 0.1% 155

Other funds holding PFE

Maven Securities's PFE Position: Q1 2026 in Review

Maven Securities opened a new position in Pfizer (PFE) in Q1 2026: 26,366 shares worth $739K. The stake represents 0.01% of the portfolio and ranks #345 among its holdings. This is a return to the name: Maven Securities previously reported a position in PFE as recently as Q3 2025.

Maven Securities first reported a position in PFE in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.5M in Q3 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Maven Securities held 26,366 shares of Pfizer worth $739K as of Q1 2026.
  • Pfizer was a new Maven Securities position in Q1 2026.
  • Pfizer made up 0.01% of Maven Securities's portfolio in Q1 2026, its #345 holding.
  • Maven Securities first reported a position in Pfizer in Q1 2020 and has held it in 15 quarters since.
  • Maven Securities's Pfizer position peaked at $1.5M in Q3 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.